Clinical Trials Using Belimumab
Clinical trials are research studies that involve people. The clinical trials on this list are studying Belimumab. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
Belimumab in Preventing Chronic Graft Versus Host Disease after Donor Stem Cell Transplant in Patients with Hematologic Malignancies
This pilot phase I trial studies the side effects of belimumab in preventing chronic graft versus host disease after a donor stem cell transplant in patients with hematologic malignancies. Sometimes the transplanted cells from a donor can attack the body's normal cells, called graft versus host disease. Giving belimumab after the transplant may stop this from happening.
Location: Siteman Cancer Center at Washington University, Saint Louis, Missouri